Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice
A Kuhlencord, T Maniera, H Eibl, C Unger, A Kuhlencord, T Maniera, H Eibl, C Unger
Abstract
Hexadecylphosphocholine (He-PC), a novel phospholipid derivative, was tested against Leishmania donovani and Leishmania infantum, the causative agents of visceral leishmaniasis. In vitro, promastigotes were highly susceptible to He-PC; the 50% inhibitory concentrations were between 0.89 and 2.25 micrograms/ml for the different leishmanial strains. In vivo, a marked antileishmanial activity in infected BALB/c mice could be demonstrated after oral administration of He-PC. Whereas parasite suppression and killing in the liver were comparable after 5 days of treatment with He-PC (10 or 20 mg/kg of body weight per day administered orally) and sodium stibogluconate (120 mg of pentavalent antimonal agent per kg/day administered subcutaneously), a superior reduction in the parasite load in the spleen and bone marrow was observed after oral treatment with He-PC. After a 4-week treatment period, parasite suppression in the spleen was better than that observed with standard sodium stibogluconate therapy by a factor of more than 600.
References
- Exp Hematol. 1992 Jan;20(1):1-5
- Am J Med. 1990 Aug;89(2):147-55
- J Cancer Res Clin Oncol. 1990;116(5):459-66
- Q J Med. 1990 Nov;77(283):1101-11
- Acta Oncol. 1989;28(2):213-7
- Trans R Soc Trop Med Hyg. 1985;79(5):715-8
- Rev Infect Dis. 1988 May-Jun;10(3):560-86
- J Infect Dis. 1980 Jul;142(1):83-6
- Ann Trop Med Parasitol. 1980 Jun;74(3):289-97
- FEBS Lett. 1991 Aug 19;288(1-2):129-32
- Cell Immunol. 1991 Oct 1;137(1):232-8
- Lancet. 1990 Dec 22-29;336(8730):1582-3
- Cancer Treat Rev. 1990 Sep;17(2-3):233-42
- J Exp Med. 1989 Jan 1;169(1):59-72
- J Infect Dis. 1989 Jul;160(1):153-8
- J Pharm Pharmacol. 1988 May;40(5):370-3
- Eur J Cancer Clin Oncol. 1988 Sep;24(9):1457-61
- Lipids. 1987 Nov;22(11):925-6
- Biochem Pharmacol. 1987 Aug 15;36(16):2633-6
- Trans R Soc Trop Med Hyg. 1983;77(2):204-7
- Ann Trop Med Parasitol. 1980 Jun;74(3):321-35
- J Parasitol. 1978 Feb;64(1):160
- J Exp Med. 1991 Oct 1;174(4):755-9
- J Lipid Mediat. 1991 Jan-Feb;3(1):71-8
- Antimicrob Agents Chemother. 1991 Jul;35(7):1403-7
- Cell Immunol. 1992 Apr 15;141(1):161-8
Source: PubMed